Cargando…
Reduced serum BDNF levels are associated with the increased risk for developing MDD: a case–control study with or without antidepressant therapy
OBJECTIVE: We do not have any consistent markers for major depressive disorder (MDD) though various biological factors are involved in the pathophysiology. We aimed to evaluate the serum brain-derived neurotrophic factor (BDNF) levels in MDD patients with or without antidepressant therapy compared t...
Autores principales: | Emon, Md. Prova Zaman, Das, Rajesh, Nishuty, Nuruna Lovely, Shalahuddin Qusar, M. M. A., Bhuiyan, Mohiuddin Ahmed, Islam, Md. Rabiul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035767/ https://www.ncbi.nlm.nih.gov/pubmed/32085720 http://dx.doi.org/10.1186/s13104-020-04952-3 |
Ejemplares similares
-
Evaluation of Serum Interleukin-6 and C-reactive Protein Levels in Drug-naïve Major Depressive Disorder Patients
por: Nishuty, Nuruna Lovely, et al.
Publicado: (2019) -
Altered IL-3 and lipocalin-2 levels are associated with the pathophysiology of major depressive disorder: a case-control study
por: Akter, Sarmin, et al.
Publicado: (2023) -
Higher serum nerve growth factor levels are associated with major
depressive disorder pathophysiology: a case–control study
por: Salsabil, Lubaba, et al.
Publicado: (2023) -
Association of reduced serum EGF and leptin levels with the pathophysiology of major depressive disorder: A case-control study
por: Sohan, Md., et al.
Publicado: (2023) -
Association of granulocyte macrophage colony-stimulating factor and interleukin-17 levels with obsessive–compulsive disorder: a case–control study findings
por: Sarker, Rapty, et al.
Publicado: (2023)